Form S-3/A SAB Biotherapeutics,
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
SAB Biotherapeutics (SABS) Announces 344.63M Share Offering by Selling Stockholders
November 20, 2023 4:49 PM ESTSAB Biotherapeutics (NASDAQ: SABS) has filed for up to 344,626,967 share offering by selling stockholders.
... More


